Search
Sagimet Biosciences Inc
SGMTAdd to Watchlist
9.110USD
-1.310-12.57%
Close 09-24 16:00（ET）
562.54MMarket Cap
LossP/E TTM
Sagimet Biosciences Inc (SGMT) Stock Price Target & Forecast
Analyst Rating
Based on 13 analysts giving stock ratings to Sagimet Biosciences Inc in the past month.
Buy
4 Strong Buy
9 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
27.545USD+164.35%
SGMT Analyst Recommendation Trends
In the current month, SGMT has received 9 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SGMT average Analyst price target in the last month is 27.545.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
4
4
4
4
4
4
4
3
9
7
7
7
7
7
7
7
0
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
13
12
12
12
12
12
12
10
SGMT Analyst Rating for Peer Comparison
Updated: Sep 24, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Beigene Ltd
ONC
8
19
0
1
0
28
argenx SE
ARGX
10
13
3
0
0
26
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
CRISPR Therapeutics AG
CRSP
4
9
11
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Insmed Inc
INSM
7
17
0
0
0
24
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Cytokinetics Inc
CYTK
4
16
2
0
0
22
Tempus AI Inc
TEM
5
6
7
1
1
20
Financial Forecasting
Based on analysts' estimates, SGMT EPS is projected to reach -0.263 in FY2026Q3, following reported EPS of -0.263 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.41
-0.37
-0.25
-0.26
-0.30
Actual
-0.29
-0.33
-0.26
--
--
Surprise
+27.68%
+12.61%
-6.70%
--
--
FAQs
What is Sagimet Biosciences Inc's price target?
Analysts forecast that Sagimet Biosciences Inc's price target is USD 29.60, with the highest forecast at USD 56.00 and the lowest forecast at USD 18.00.
How have Sagimet Biosciences IncSGMT's recent earnings per share performed?
The market expectation was USD -0.26, while Sagimet Biosciences IncSGMT's earnings per share (EPS) for the previous quarter was USD -0.33. EPS for the next quarter is expected at USD -0.26.
What is the analyst rating for Sagimet Biosciences Inc?
Based on the ratings of Sagimet Biosciences Inc's stock from 13 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.